Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10154974

Use of abscisic acid for the prevention and treatment of malaria

The Regents of the University of California · Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10151763

Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome

Corcept Therapeutics Incorporated · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149847

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

Lixte Biotechnology, Inc. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149836

Isoxazole treatments for frontotemporal dementia

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149829

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10144726

Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-nega

SENTINEL ONCOLOGY LIMITED · Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10144743

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative di

Takeda Pharmaceutical Company Limited · Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10137133

Methods for treatment of diseases

Galera Labs, LLC · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10137130

Methods of treatment of malignancies

Agios Pharmaceuticals, Inc. · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10132810

Method for assessing and predicting efficacy of breast cancer treatment with a long-acting

Nektar Therapeutics · Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10130594

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10123759

Systems, compositions, and methods for local imaging and treatment of pain

The Regents of the University of California · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117947

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10118904

Triazoles for the treatment of Demyelinating Diseases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117907

Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegen

Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111878

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitor

Agios Pharmaceuticals, Inc. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10113183

Adeno-associated virus vectors for treatment of glycogen storage disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10113151

Composition of viral vectors in lecithin liposomes, preparation method and treatment metho

The Regents of the University of California · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111865

Methods of sedation during critical care treatment

OVID THERAPEUTICS INC. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111862

Traps in the treatment of macular degeneration

Aldeyra Therapeutics, Inc. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111861

Treatment of breast cancer

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10105436

Smallpox vaccine for cancer treatment

Calidi Biotherapeutics, Inc. · Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10105341

Treatment for obesity

Jazz Pharmaceuticals International III Limited · Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10100049

JAK kinase inhibitor compounds for treatment of respiratory disease

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted